Literature DB >> 1448106

Multiple mechanisms of interference between transformation and differentiation in thyroid cells.

H Francis-Lang1, M Zannini, M De Felice, M T Berlingieri, A Fusco, R Di Lauro.   

Abstract

Transformation of the thyroid cell line FRTL-5 results in loss or reduction of differentiation as measured by the expression of thyroglobulin and thyroperoxidase, two proteins whose genes are exclusively expressed in thyroid follicular cells. The biochemical mechanisms leading to this phenomenon were investigated in three cell lines obtained by transformation of FRTL-5 cells with Ki-ras, Ha-ras, and polyomavirus middle-T oncogenes. With the ras oncogenes, transformation leads to undetectable expression of the thyroglobulin and thyroperoxidase genes. However, the mechanisms responsible for the extinction of the differentiated phenotype seem to be different for the two ras oncogenes. In Ki-ras-transformed cells, the mRNA encoding TTF-1, a transcription factor controlling thyroglobulin and thyroperoxidase gene expression, is severely reduced. On the contrary, nearly wild-type levels of TTF-1 mRNA are detected in Ha-ras-transformed cells. Furthermore, overexpression of TTF-1 can activate transcription of the thyroglobulin promoter in Ki-ras-transformed cells, whereas it has no effect on thyroglobulin transcription in the Ha-ras-transformed line. Expression of polyoma middle-T antigen in thyroid cells leads to only a reduction of differentiation and does not severely affect either the activity or the amount of TTF-1. Another thyroid cell-specific transcription factor, TTF-2, is more sensitive to transformation, since it disappears in all three transformed lines, and probably contributes to the reduced expression of the differentiated phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448106      PMCID: PMC360519          DOI: 10.1128/mcb.12.12.5793-5800.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.

Authors:  B Binétruy; T Smeal; M Karin
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

Review 2.  Oncogenic conversion by regulatory changes in transcription factors.

Authors:  B Lewin
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Reactivation of thyroglobulin gene expression in transformed thyroid cells by 5-azacytidine.

Authors:  E V Avvedimento; S Obici; M Sanchez; A Gallo; A Musti; M E Gottesman
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

4.  Cooperation between the polyomavirus middle-T-antigen gene and the human c-myc oncogene in a rat thyroid epithelial differentiated cell line: model of in vitro progression.

Authors:  M T Berlingieri; G Portella; M Grieco; M Santoro; A Fusco
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

5.  Hormonal regulation of thyroid peroxidase in normal and transformed rat thyroid cells.

Authors:  R Zarrilli; S Formisano; B Di Jeso
Journal:  Mol Endocrinol       Date:  1990-01

6.  Thyrotropin receptor gene expression in oncogene-transfected rat thyroid cells: correlation between transformation, loss of thyrotropin-dependent growth, and loss of thyrotropin receptor gene expression.

Authors:  M T Berlingieri; T Akamizu; A Fusco; M Grieco; G Colletta; A M Cirafici; S Ikuyama; L D Kohn; G Vecchio
Journal:  Biochem Biophys Res Commun       Date:  1990-11-30       Impact factor: 3.575

7.  The deoxyribonucleic acid regions involved in the hormonal regulation of thyroglobulin gene expression.

Authors:  N T Lee; K Kamikubo; K J Chai; L R Kao; A J Sinclair; S N Nayfeh; C B Chae
Journal:  Endocrinology       Date:  1991-01       Impact factor: 4.736

8.  v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor.

Authors:  V R Baichwal; A Park; R Tjian
Journal:  Nature       Date:  1991-07-11       Impact factor: 49.962

9.  Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter.

Authors:  P Santisteban; A Acebrón; M Polycarpou-Schwarz; R Di Lauro
Journal:  Mol Endocrinol       Date:  1992-08

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  27 in total

1.  Expression and function of the homeodomain-containing protein Hex in thyroid cells.

Authors:  L Pellizzari; A D'Elia; A Rustighi; G Manfioletti; G Tell; G Damante
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

Review 2.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  Thyroid-specific transcription factors control Hex promoter activity.

Authors:  Cinzia Puppin; Angela V D'Elia; Lucia Pellizzari; Diego Russo; Franco Arturi; Ivan Presta; Sebastiano Filetti; Clifford W Bogue; Lee A Denson; Giuseppe Damante
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

4.  DARPP-32 is required for MAPK/ERK signaling in thyroid cells.

Authors:  Ana Chocarro-Calvo; Miguel A Zaballos; Pilar Santisteban; Custodia García-Jiménez
Journal:  Mol Endocrinol       Date:  2012-02-02

5.  Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.

Authors:  Laura Casalino; Latifa Bakiri; Francesco Talotta; Jonathan B Weitzman; Alfredo Fusco; Moshe Yaniv; Pasquale Verde
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

6.  Conservation across species identifies several transcriptional enhancers in the HEX genomic region.

Authors:  Angela Valentina D'Elia; Elisa Bregant; Nadia Passon; Cinzia Puppin; Alessia Meneghel; Giuseppe Damante
Journal:  Mol Cell Biochem       Date:  2009-06-25       Impact factor: 3.396

7.  TITF1 and TITF2 loci variants indicate significant associations with thyroid cancer.

Authors:  Peiliang Geng; Juanjuan Ou; Jianjun Li; Yunmei Liao; Ning Wang; Ganfeng Xie; Rina Sa; Chen Liu; Lisha Xiang; Houjie Liang
Journal:  Endocrine       Date:  2015-07-25       Impact factor: 3.633

8.  Oncogenic ras blocks the cAMP pathway and dedifferentiates thyroid cells via an impairment of pax8 transcriptional activity.

Authors:  Maria Giuseppina Baratta; Immacolata Porreca; Roberto Di Lauro
Journal:  Mol Endocrinol       Date:  2009-03-12

9.  Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation.

Authors:  Elisa Bregant; Giovanni Renzone; Renata Lonigro; Nadia Passon; Carla Di Loreto; Maura Pandolfi; Andrea Scaloni; Gianluca Tell; Giuseppe Damante
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

10.  Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Authors:  Alan L Ho; Ravinder K Grewal; Rebecca Leboeuf; Eric J Sherman; David G Pfister; Desiree Deandreis; Keith S Pentlow; Pat B Zanzonico; Sofia Haque; Somali Gavane; Ronald A Ghossein; Julio C Ricarte-Filho; José M Domínguez; Ronglai Shen; R Michael Tuttle; Steve M Larson; James A Fagin
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.